BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 37499762)

  • 1. Cumulative steroid dose in hospitalized patients and COVID-19-associated pulmonary aspergillosis.
    Ramonfaur D; Salto-Quintana JN; Aguirre-García GM; Hernández-Mata NM; Villanueva-Lozano H; Torre-Amione G; Martínez-Reséndez MF
    J Hosp Infect; 2023 Dec; 142():26-31. PubMed ID: 37499762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
    Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
    Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
    Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
    J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
    Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
    Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
    Hurt W; Youngs J; Ball J; Edgeworth J; Hopkins P; Jenkins DR; Leaver S; Mazzella A; Molloy SF; Schelenz S; Wise MP; White PL; Yusuff H; Wyncoll D; Bicanic T
    Thorax; 2023 Dec; 79(1):75-82. PubMed ID: 37657925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.
    Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A;
    Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
    Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
    J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study.
    Lee R; Cho SY; Lee DG; Ahn H; Choi H; Choi SM; Choi JK; Choi JH; Kim SY; Kim YJ; Lee HJ
    Korean J Intern Med; 2022 Jul; 37(4):851-863. PubMed ID: 35611611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
    Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
    Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
    Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
    Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
    Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
    BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.
    Leistner R; Schroeter L; Adam T; Poddubnyy D; Stegemann M; Siegmund B; Maechler F; Geffers C; Schwab F; Gastmeier P; Treskatsch S; Angermair S; Schneider T
    Crit Care; 2022 Jan; 26(1):30. PubMed ID: 35090528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
    van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
    J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.
    Nasir N; Farooqi J; Mahmood SF; Jabeen K
    Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
    Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
    Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
    Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
    Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis.
    Gioia F; Walti LN; Orchanian-Cheff A; Husain S
    Lancet Respir Med; 2024 Mar; 12(3):207-216. PubMed ID: 38185135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case-Control Study.
    Calderón-Parra J; Moreno-Torres V; Mills-Sanchez P; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A
    J Fungi (Basel); 2022 Feb; 8(2):. PubMed ID: 35205914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.